Throughout the life course, higher body mass index and obesity are linked to cognitive decline, brain atrophy, reduced white matter and integrity of the blood-brain barrier, and elevated risk for late-onset Alzheimer disease.
Stress is linked to impaired sleep and increased cravings for unhealthy foods which can ultimately lead to obesity.
No correlation was found for cognitive function with changes in weight or fitness.
Being overweight may slightly lower chances for hemorrhagic stroke, the study found.
Medication, plus a relatively sedentary lifestyle, places people with epilepsy at great risk of metabolic syndrome and its various complications.
A transition from overweight to obese correlated with a 41% increased risk of MS.
A comprehensive approach to managing depression may have far-reaching effects.
Differences in cortical thickness were not seen in participants who were overweight or lean.
Patients who underwent gastric bypass surgery saw improved nerve fiber density 12 months following surgery.
Food smells generate impulsive reaction in obese children.
Two genetic variants appear to heighten brain reward responses to foods that are high in fat and sugar.
Obesity is comorbid with migraine, and migraine risk correlates with increasing obesity status.
48% of shift workers were likely to be overweight compared to 35% of people who didn't do shift work.
Activation of the PVH MC4R-LPBN circuit was associated with a reduction in food consumption.
Experts are challenging the study's methods since both weight and dementia have genetic components.
As little as 30 minutes of lost sleep significantly affects risk of being obese or developing diabetes.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies